Lavaca Capital LLC Amgen Inc Transaction History

Lavaca Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $817,530 - $906,990	-3,500 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$221.91 - $258.6 $410,977 - $478,927	1,852 Added 112.38%	3,500 $871,000
Q4 2020 Jan 13, 2021	BUY	$216.38 - $257.67 $161,852 - $192,737	748 Added 83.11%	1,648 $379,000
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $211,185 - $234,855	900 New	900 $229,000
Q2 2019 Jul 29, 2019	SELL	$166.7 - $195.41 $66,680 - $78,164	-400 Closed	0 $0
Q4 2018 Jan 22, 2019	BUY	$178.4 - $208.25 $71,360 - $83,300	400 New	400 $78,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Lavaca Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Lavaca Capital LLC with notifications on news.